ALK1 signaling in development and disease: new paradigms

[1]  L. Young,et al.  Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of Pulmonary Arteriovenous Malformations , 2017, American journal of respiratory and critical care medicine.

[2]  R. Adams,et al.  Dll4 and Notch signalling couples sprouting angiogenesis and artery formation , 2017, Nature Cell Biology.

[3]  Arndt F. Siekmann,et al.  Endothelial Notch signalling limits angiogenesis via control of artery formation , 2017, Nature Cell Biology.

[4]  D. de Sanctis,et al.  Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1 , 2017, Cell reports.

[5]  G. Blobe,et al.  Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Cornelia Denz,et al.  Endoglin controls blood vessel diameter through endothelial cell shape changes in response to haemodynamic cues , 2017, Nature Cell Biology.

[7]  C. Betsholtz,et al.  Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling , 2017, Nature Cell Biology.

[8]  S. Steinberg,et al.  Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma , 2017, Clinical Cancer Research.

[9]  D. Stainier,et al.  Vegf signaling promotes vascular endothelial differentiation by modulating etv2 expression. , 2017, Developmental biology.

[10]  R. Karas,et al.  Conditional knockout of activin like kinase-1 (ALK-1) leads to heart failure without maladaptive remodeling , 2017, Heart and Vessels.

[11]  Ying E. Zhang.  Non-Smad Signaling Pathways of the TGF-β Family. , 2017, Cold Spring Harbor perspectives in biology.

[12]  S. Steinberg,et al.  A Phase II Clinical Trial of TRC105 (Anti‐Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma , 2017, Clinical genitourinary cancer.

[13]  M. Atkins,et al.  The DART Study: Results from the Dose-Escalation and Expansion Cohorts Evaluating the Combination of Dalantercept plus Axitinib in Advanced Renal Cell Carcinoma , 2016, Clinical Cancer Research.

[14]  A. Hinck,et al.  Structural Biology and Evolution of the TGF-β Family. , 2016, Cold Spring Harbor perspectives in biology.

[15]  W. Sessa,et al.  PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia , 2016, Nature Communications.

[16]  C. Ramírez,et al.  Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells , 2016, Nature Communications.

[17]  Katie Bentley,et al.  Asymmetric division coordinates collective cell migration in angiogenesis , 2016, Nature Cell Biology.

[18]  Troy C. Krzysiak,et al.  Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling , 2016, Biochemistry.

[19]  F. Campagne,et al.  A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10 , 2016, Scientific Reports.

[20]  T. Ross,et al.  Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia , 2016, The Journal of cell biology.

[21]  B. Gilbert-Dussardier,et al.  Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia: A Randomized Clinical Trial. , 2016, JAMA.

[22]  C. Merlo,et al.  Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. , 2016, JAMA.

[23]  T. Nakanishi,et al.  Identification of multiple ACVRL1 mutations in patients with pulmonary arterial hypertension by targeted exome capture. , 2016, Clinical science.

[24]  Bin Zhou,et al.  Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells , 2016, Nature Communications.

[25]  C. Cui,et al.  Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer , 2016, Oncogene.

[26]  C. Hill.  Transcriptional Control by the SMADs. , 2016, Cold Spring Harbor perspectives in biology.

[27]  Prahlad G. Menon,et al.  Alk1 controls arterial endothelial cell migration in lumenized vessels , 2016, Development.

[28]  S. P. Oh,et al.  Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation , 2016, Angiogenesis.

[29]  D. Stainier,et al.  In vivo modulation of endothelial polarization by Apelin receptor signalling , 2016, Nature Communications.

[30]  M. Bhasin,et al.  Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma , 2016, Oncotarget.

[31]  C. Preece,et al.  An Intronic Flk1 Enhancer Directs Arterial-Specific Expression via RBPJ-Mediated Venous Repression , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[32]  R. Kelsh,et al.  Clarification of mural cell coverage of vascular endothelial cells by live imaging of zebrafish , 2016, Development.

[33]  C. Baldock,et al.  Extracellular Regulation of Bone Morphogenetic Protein Activity by the Microfibril Component Fibrillin-1* , 2016, The Journal of Biological Chemistry.

[34]  C. Mummery,et al.  Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[35]  F. Blanco,et al.  Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response , 2016, PLoS genetics.

[36]  M. Mcgoon,et al.  Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. , 2016, Chest.

[37]  C. Bernabéu,et al.  Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia , 2016, Thrombosis and Haemostasis.

[38]  Y. Kienast,et al.  Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains* , 2015, The Journal of Biological Chemistry.

[39]  Wei Li,et al.  The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells , 2015, The Journal of Biological Chemistry.

[40]  L. Liaw,et al.  DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1 , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[41]  S. Steinberg,et al.  A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib , 2015, United European gastroenterology journal.

[42]  M. Goumans,et al.  Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors , 2015, Clinical Cancer Research.

[43]  Phillip C. Yang,et al.  Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. , 2015, American journal of respiratory and critical care medicine.

[44]  B. L. Roman,et al.  Context-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations. , 2015, Cardiovascular research.

[45]  C. Aghajanian,et al.  Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N. , 2015, Gynecologic oncology.

[46]  C. Rooryck,et al.  BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus , 2015, Proceedings of the National Academy of Sciences.

[47]  V. Vorselaars,et al.  Pulmonary hypertension in hereditary haemorrhagic telangiectasia. , 2015, World journal of cardiology.

[48]  Arndt F. Siekmann,et al.  Chemokine-guided angiogenesis directs coronary vasculature formation in zebrafish. , 2015, Developmental cell.

[49]  S. Gräf,et al.  Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension , 2015, Nature Medicine.

[50]  C. McCulloch,et al.  Hemorrhage Rates From Brain Arteriovenous Malformation in Patients With Hereditary Hemorrhagic Telangiectasia , 2015, Stroke.

[51]  B. Conley,et al.  BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses , 2015, PloS one.

[52]  S. Erzurum,et al.  Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling. , 2015, American journal of respiratory and critical care medicine.

[53]  Elizabeth A. V. Jones,et al.  Notch1 Is Pan-Endothelial at the Onset of Flow and Regulated by Flow , 2015, PloS one.

[54]  Holger Gerhardt,et al.  Dynamic Endothelial Cell Rearrangements Drive Developmental Vessel Regression , 2015, PLoS biology.

[55]  Andreas Fischer,et al.  Serum Induces Transcription of Hey1 and Hey2 Genes by Alk1 but Not Notch Signaling in Endothelial Cells , 2015, PloS one.

[56]  T. Walz,et al.  Structure of bone morphogenetic protein 9 procomplex , 2015, Proceedings of the National Academy of Sciences.

[57]  S. P. Oh,et al.  Essential role for TMEM100 in vascular integrity but limited contributions to the pathogenesis of hereditary haemorrhagic telangiectasia. , 2015, Cardiovascular research.

[58]  D. Finegold,et al.  Genetic and Molecular Basis for Hereditary Hemorrhagic Telangiectasia , 2015, Current Genetic Medicine Reports.

[59]  V. Tiwari,et al.  Tmem100 Is a Regulator of TRPA1-TRPV1 Complex and Contributes to Persistent Pain , 2015, Neuron.

[60]  S. Giraud,et al.  Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function. , 2015, Human molecular genetics.

[61]  P. Bayrak-Toydemir,et al.  Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era , 2015, Front. Genet..

[62]  B. Seon,et al.  Facilitation of endoglin‐targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105) , 2015, International journal of cancer.

[63]  A. Harris,et al.  A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis , 2015, Angiogenesis.

[64]  C. Shovlin.  Pulmonary arteriovenous malformations. , 2014, American journal of respiratory and critical care medicine.

[65]  S. Qi,et al.  Bone Morphogenetic Protein‐10 Induces Cardiomyocyte Proliferation and Improves Cardiac Function After Myocardial Infarction , 2014, Journal of cellular biochemistry.

[66]  S. Choe,et al.  Common and Distinctive Pathogenetic Features of Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia 1 and Hereditary Hemorrhagic Telangiectasia 2 Animal Models—Brief Report , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[67]  D. Matei,et al.  An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer , 2014, Clinical Cancer Research.

[68]  P. Plinkert,et al.  Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study. , 2014, Thrombosis research.

[69]  U. R. Michaelis.  Mechanisms of endothelial cell migration , 2014, Cellular and Molecular Life Sciences.

[70]  B. Sorg,et al.  VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2 , 2014, Angiogenesis.

[71]  Richard J. Poole,et al.  SoxF factors and Notch regulate nr2f2 gene expression during venous differentiation in zebrafish. , 2014, Developmental biology.

[72]  V. Kaartinen,et al.  Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression , 2014, PloS one.

[73]  Aline M. Betancourt,et al.  Pericyte Dynamics during Angiogenesis: New Insights from New Identities , 2014, Journal of Vascular Research.

[74]  Arndt F. Siekmann,et al.  Distinct Notch signaling outputs pattern the developing arterial system , 2014, Development.

[75]  E. van Nimwegen,et al.  Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial–mesenchymal transition , 2014, Journal of Cell Science.

[76]  M. Santoro,et al.  An α-Smooth Muscle Actin (acta2/αsma) Zebrafish Transgenic Line Marking Vascular Mural Cells and Visceral Smooth Muscle Cells , 2014, PloS one.

[77]  W. Young,et al.  Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia , 2014, PloS one.

[78]  Nicholas W Morrell,et al.  Relevant issues in the pathology and pathobiology of pulmonary hypertension. , 2013, Journal of the American College of Cardiology.

[79]  Martin Jones,et al.  Computer simulations reveal complex distribution of haemodynamic forces in a mouse retina model of angiogenesis , 2013, Journal of The Royal Society Interface.

[80]  Suzanne F. Jones,et al.  Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer , 2013, Clinical Cancer Research.

[81]  Hiroshi I. Suzuki,et al.  Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression , 2013, Proceedings of the National Academy of Sciences.

[82]  Ryan S. Udan,et al.  Dynamic responses of endothelial cells to changes in blood flow during vascular remodeling of the mouse yolk sac , 2013, Development.

[83]  H. Gerhardt,et al.  Filopodia are dispensable for endothelial tip cell guidance , 2013, Development.

[84]  Brendan D. O'Fallon,et al.  BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. , 2013, American journal of human genetics.

[85]  B. L. Roman,et al.  Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence , 2013, Development.

[86]  Semion K. Saikin,et al.  The nucleus of endothelial cell as a sensor of blood flow direction , 2013, Biology Open.

[87]  D. Bernstein,et al.  FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. , 2013, The Journal of clinical investigation.

[88]  D. Rifkin,et al.  Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation. , 2013, Cytokine & growth factor reviews.

[89]  T. Zimmers,et al.  Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. , 2013, Blood.

[90]  Ke Liu,et al.  Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development , 2013, Proceedings of the National Academy of Sciences.

[91]  M. Affolter,et al.  The zebrafish common cardinal veins develop by a novel mechanism: lumen ensheathment , 2013, Development.

[92]  Y. Muller,et al.  Identification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3) , 2013, PloS one.

[93]  S. Warming,et al.  Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development , 2013, Proceedings of the National Academy of Sciences.

[94]  J. Saurin,et al.  Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences. , 2013, European journal of internal medicine.

[95]  A. Luttun,et al.  COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1 , 2013, Journal of Cell Science.

[96]  S. Friedman,et al.  Vascular Injury Triggers Krüppel-Like Factor 6 Mobilization and Cooperation With Specificity Protein 1 to Promote Endothelial Activation Through Upregulation of the Activin Receptor-Like Kinase 1 Gene , 2013, Circulation research.

[97]  L. Liaw,et al.  BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. , 2012, Blood.

[98]  A. Hinck,et al.  Structure of the Alk1 extracellular domain and characterization of its bone morphogenetic protein (BMP) binding properties. , 2012, Biochemistry.

[99]  Chun Li,et al.  Haemodynamics-Driven Developmental Pruning of Brain Vasculature in Zebrafish , 2012, PLoS biology.

[100]  O. Nakagawa,et al.  Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis , 2012, Proceedings of the National Academy of Sciences.

[101]  David S Mendelson,et al.  A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer , 2012, Clinical Cancer Research.

[102]  A. Hinck.  Structural studies of the TGF‐βs and their receptors – insights into evolution of the TGF‐β superfamily , 2012, FEBS letters.

[103]  W. Young,et al.  Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain , 2012, Stroke.

[104]  T. Zimmers,et al.  BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. , 2012, Blood.

[105]  A. Grinberg,et al.  Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex , 2012, The Journal of Biological Chemistry.

[106]  C. Hughes,et al.  BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II , 2012, Angiogenesis.

[107]  W. Young,et al.  Minimal Homozygous Endothelial Deletion of Eng with VEGF Stimulation Is Sufficient to Cause Cerebrovascular Dysplasia in the Adult Mouse , 2012, Cerebrovascular Diseases.

[108]  A. Eichmann,et al.  ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. , 2012, Developmental cell.

[109]  J. Saurin,et al.  Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. , 2012, JAMA.

[110]  T. Davidson,et al.  Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy , 2012, The Laryngoscope.

[111]  V. Rubio,et al.  Structural and Functional Insights into Endoglin Ligand Recognition and Binding , 2012, PloS one.

[112]  I. Adcock,et al.  BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production , 2012, PloS one.

[113]  T. Yamazaki,et al.  Discovery of a novel neuroprotective compound, AS1219164, by high-throughput chemical screening of a newly identified apoptotic gene marker. , 2011, European journal of pharmacology.

[114]  Yukiko Kurihara,et al.  Angiogenic morphogenesis driven by dynamic and heterogeneous collective endothelial cell movement , 2011, Development.

[115]  C. Harrison,et al.  Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands , 2011, Growth factors.

[116]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[117]  Shuichi Tsutsumi,et al.  ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif , 2011, Nucleic acids research.

[118]  N. Solban,et al.  Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth* , 2011, The Journal of Biological Chemistry.

[119]  L. David,et al.  BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain , 2011, Cellular and Molecular Life Sciences.

[120]  A. Luttun,et al.  Transcription factor COUP-TFII is indispensable for venous and lymphatic development in zebrafish and Xenopus laevis. , 2011, Biochemical and biophysical research communications.

[121]  Nicola Elvassore,et al.  Role of YAP/TAZ in mechanotransduction , 2011, Nature.

[122]  M. Lawton,et al.  Arteriovenous malformation in the adult mouse brain resembling the human disease , 2011, Annals of neurology.

[123]  Annik Prat,et al.  Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10* , 2011, The Journal of Biological Chemistry.

[124]  F. Sanz‐Rodríguez,et al.  Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells , 2011, Molecular Pharmacology.

[125]  J. Gutkind,et al.  Assembly and patterning of the vascular network of the vertebrate hindbrain , 2011, Development.

[126]  K. Pekkan,et al.  Interaction between alk1 and blood flow in the development of arteriovenous malformations , 2011, Development.

[127]  Youliang Wang,et al.  Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. , 2011, Developmental cell.

[128]  J. Hao,et al.  Distinct Signaling Pathways Regulate Sprouting Angiogenesis from the Dorsal Aorta and Axial Vein , 2011, Nature Cell Biology.

[129]  T. Davidson,et al.  Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia‐associated epistaxis , 2011, The Laryngoscope.

[130]  R. Simon,et al.  Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. , 2011, Cancer research.

[131]  Takako Sasaki,et al.  Prodomains of Transforming Growth Factor β (TGFβ) Superfamily Members Specify Different Functions , 2010, The Journal of Biological Chemistry.

[132]  S. P. Oh,et al.  Generation of mice with a conditional and reporter allele for Tmem100 , 2010, Genesis.

[133]  H. Gerhardt,et al.  Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting , 2010, Nature Cell Biology.

[134]  A. Hata,et al.  Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. , 2010, Molecular cell.

[135]  Joshua S. Kaminker,et al.  Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching. , 2010, Blood.

[136]  K. Miyazono,et al.  BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo , 2010, Journal of Cell Science.

[137]  Rachael J. Oakenfull,et al.  Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.

[138]  A. Chervonsky,et al.  Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants , 2010, Genesis.

[139]  C. Bernabéu,et al.  Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells , 2010, Thrombosis and Haemostasis.

[140]  N. Solban,et al.  ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth , 2010, Molecular Cancer Therapeutics.

[141]  W. Reardon,et al.  Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP–HHT syndrome , 2010, American journal of medical genetics. Part A.

[142]  M. Goumans,et al.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis , 2010, The Journal of experimental medicine.

[143]  A. Hinck,et al.  Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor. , 2009, Biochemistry.

[144]  B. Sorg,et al.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. , 2009, Journal of Clinical Investigation.

[145]  M. Letarte,et al.  Endoglin is dispensable for angiogenesis, but required for endocardial cushion formation in the midgestation mouse embryo. , 2009, Developmental biology.

[146]  D. Stainier,et al.  Characterization of vascular mural cells during zebrafish development , 2009, Mechanisms of Development.

[147]  R. Trembath,et al.  Genetics and genomics of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[148]  R. Trembath,et al.  Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells* , 2009, The Journal of Biological Chemistry.

[149]  G. Steinberg,et al.  Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. , 2009, Human molecular genetics.

[150]  R. Matsuoka,et al.  A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension , 2009, Journal of Medical Genetics.

[151]  L. Alfredsson,et al.  The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case–control study using the General Practice Research Database , 2009, BJOG : an international journal of obstetrics and gynaecology.

[152]  J. Mulliken,et al.  Somatic Mutations in the Angiopoietin-Receptor TIE2 Can Cause Both Solitary and Multiple Sporadic Venous Malformations , 2008, Nature Genetics.

[153]  C. Eng,et al.  BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia , 2008, American journal of medical genetics. Part A.

[154]  Masahiro Sokabe,et al.  Mechanical forces facilitate actin polymerization at focal adhesions in a zyxin-dependent manner , 2008, Journal of Cell Science.

[155]  Tyson N. Kim,et al.  Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice , 2008, Proceedings of the National Academy of Sciences.

[156]  Takako Sasaki,et al.  Targeting of Bone Morphogenetic Protein Growth Factor Complexes to Fibrillin* , 2008, Journal of Biological Chemistry.

[157]  L. David,et al.  Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.

[158]  L. Adams,et al.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[159]  V. Kaartinen,et al.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. , 2008, Blood.

[160]  M. Hecker,et al.  Cyclic Stretch Controls the Expression of CD40 in Endothelial Cells by Changing Their Transforming Growth Factor–&bgr;1 Response , 2007, Circulation.

[161]  Samy Lamouille,et al.  Activin receptor‐like kinase 1 inhibits human microvascular endothelial cell migration: Potential roles for JNK and ERK , 2007, Journal of cellular physiology.

[162]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[163]  Scott E Fraser,et al.  Vascular remodeling of the mouse yolk sac requires hemodynamic force , 2007, Development.

[164]  Wenlong Li,et al.  Essential Role of Endothelial Smad4 in Vascular Remodeling and Integrity , 2007, Molecular and Cellular Biology.

[165]  M. Eyries,et al.  Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia , 2007, European journal of clinical investigation.

[166]  C. Sabbà,et al.  Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers , 2007, Journal of thrombosis and haemostasis : JTH.

[167]  K. Boström,et al.  Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells. , 2007, Cardiovascular research.

[168]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[169]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[170]  Adam L. Bermange,et al.  Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis , 2007, Development.

[171]  G. Thurston,et al.  Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting , 2007, Proceedings of the National Academy of Sciences.

[172]  Holger Gerhardt,et al.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.

[173]  Nathan D. Lawson,et al.  Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries , 2007, Nature.

[174]  M. Rondaij,et al.  KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. , 2006, Blood.

[175]  B. L. Langille,et al.  Shear Stress Regulates Forward and Reverse Planar Cell Polarity of Vascular Endothelium In Vivo and In Vitro , 2006, Circulation research.

[176]  R. Pyeritz,et al.  SMAD4 mutations found in unselected HHT patients , 2006, Journal of Medical Genetics.

[177]  John Garland,et al.  ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-β and constitutively active receptor induced gene expression , 2006, BMC cardiovascular disorders.

[178]  M. Kurabayashi,et al.  Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. , 2006, Biochemical and biophysical research communications.

[179]  P. Bayrak-Toydemir,et al.  Genotype–phenotype correlation in hereditary hemorrhagic telangiectasia: Mutations and manifestations * , 2006, American journal of medical genetics. Part A.

[180]  Yuzhi Zhang,et al.  Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. , 2005, The Journal of clinical investigation.

[181]  D. Lindhout,et al.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia , 2005, Journal of Medical Genetics.

[182]  Jurgen Seppen,et al.  Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. , 2005, The American journal of pathology.

[183]  J. Wrana,et al.  Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor β1 with Higher Affinity Receptors and an Activated Alk1 Pathway* , 2005, Journal of Biological Chemistry.

[184]  Z. Werb,et al.  Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[185]  Mallika Singh,et al.  Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.

[186]  Fu-Jung Lin,et al.  Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity , 2005, Nature.

[187]  M. Capogrossi,et al.  Laminar shear stress inhibits CXCR4 expression on endothelial cells: functional consequences for atherogenesis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[188]  Tasuku Honjo,et al.  Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. , 2004, Genes & development.

[189]  Janet Rossant,et al.  Dosage-sensitive requirement for mouse Dll4 in artery development. , 2004, Genes & development.

[190]  D. Banville,et al.  Endoglin Regulates Cytoskeletal Organization through Binding to ZRP-1, a Member of the Lim Family of Proteins* , 2004, Journal of Biological Chemistry.

[191]  A. Moorman,et al.  Expression of bone morphogenetic protein-10 mRNA during chicken heart development. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[192]  Joshua D. Smith,et al.  Endoglin Controls Cell Migration and Composition of Focal Adhesions , 2004, Journal of Biological Chemistry.

[193]  Michael D. Schneider,et al.  BMP10 is essential for maintaining cardiac growth during murine cardiogenesis , 2004, Development.

[194]  A. Rustgi,et al.  A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) , 2004, The Lancet.

[195]  M. Goumans,et al.  Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells , 2004, The EMBO journal.

[196]  M. Kessel,et al.  Highly restricted BMP10 expression in the trabeculating myocardium of the chick embryo , 2004, Development Genes and Evolution.

[197]  R. Trembath,et al.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia , 2003, Journal of medical genetics.

[198]  T. Seki,et al.  Arterial Endothelium-Specific Activin Receptor-Like Kinase 1 Expression Suggests Its Role in Arterialization and Vascular Remodeling , 2003, Circulation research.

[199]  Jonas Larsson,et al.  Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. , 2003, Molecular cell.

[200]  Dean Y. Li,et al.  Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. , 2003, Developmental biology.

[201]  J. Soames,et al.  Mouse Model for Hereditary Hemorrhagic Telangiectasia Has a Generalized Vascular Abnormality , 2003, Circulation.

[202]  M. Porteous,et al.  A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. , 2003, Human molecular genetics.

[203]  Samy Lamouille,et al.  Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. , 2002, Blood.

[204]  Hiroyuki Aburatani,et al.  Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells , 2002, Journal of cellular physiology.

[205]  P. D. de Groot,et al.  Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2). , 2002, Blood.

[206]  B. Weinstein,et al.  sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. , 2002, Developmental cell.

[207]  R. Moon,et al.  Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. , 2002, Development.

[208]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[209]  M. Letarte,et al.  Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. , 2001, Blood.

[210]  J. Campos-Ortega,et al.  Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.

[211]  M. Humbert,et al.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.

[212]  S. Rutella,et al.  CD105 (Endoglin) Expression on Hematopoietic Stem/Progenitor Cells , 2001, Leukemia & lymphoma.

[213]  Dean Y. Li,et al.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.

[214]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[215]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[216]  R. Thies,et al.  Bone Morphogenetic Protein-9 , 2000, The Journal of Biological Chemistry.

[217]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[218]  D. Dumont,et al.  A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.

[219]  S. Soker,et al.  Vascular Endothelial Growth Factor Effect on Endothelial Cell Proliferation, Migration, and Platelet-activating Factor Synthesis Is Flk-1-dependent* , 1999, The Journal of Biological Chemistry.

[220]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[221]  L. Attisano,et al.  Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1* , 1999, The Journal of Biological Chemistry.

[222]  H. Kleinman,et al.  Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells: In Vivo Neovascularization Induced by Stromal-Derived Factor-1α , 1999 .

[223]  J. Massagué,et al.  Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors* , 1999, The Journal of Biological Chemistry.

[224]  V. Rosen,et al.  Heart specific expression of mouse BMP-10 a novel member of the TGF-β superfamily , 1999, Mechanisms of Development.

[225]  J. Wrana,et al.  Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.

[226]  P. Krieg,et al.  VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. , 1998, Development.

[227]  C. Heldin,et al.  The L45 loop in type I receptors for TGF‐β family members is a critical determinant in specifying Smad isoform activation , 1998, FEBS letters.

[228]  J. Massagué,et al.  Determinants of specificity in TGF-beta signal transduction. , 1998, Genes & development.

[229]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[230]  N. McKee,et al.  Evidence for the migration of rat aortic endothelial cells toward the heart. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[231]  C. J. Gimeno,et al.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[232]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[233]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[234]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[235]  R. Leduc,et al.  Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*) , 1995, The Journal of Biological Chemistry.

[236]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[237]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[238]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[239]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[240]  M. Porteous,et al.  Hereditary haemorrhagic telangiectasia: a clinical analysis. , 1992, Journal of medical genetics.

[241]  Brownlee Rd,et al.  Arterial adaptations to altered blood flow. , 1991 .

[242]  P. Coulson,et al.  Portal shunting and resistance to Schistosoma mansoni in 129 strain mice , 1989, Parasitology.

[243]  Y. Yazaki,et al.  Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. , 1989, Biochemical and biophysical research communications.

[244]  B L Langille,et al.  Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. , 1989, The American journal of physiology.

[245]  B L Langille,et al.  Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. , 1986, Science.

[246]  K. Rogers,et al.  Comparison of the cytoskeleton in aortic endothelial cells in situ and in vitro. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[247]  T Togawa,et al.  Adaptive regulation of wall shear stress to flow change in the canine carotid artery. , 1980, The American journal of physiology.

[248]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[249]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[250]  Richard Thoma,et al.  Untersuchungen über die Histogenese und Histomechanik des Gefässsystems , 1894 .

[251]  S. Childs,et al.  Patterning mechanisms of the sub-intestinal venous plexus in zebrafish. , 2016, Developmental biology.

[252]  G. Bręborowicz,et al.  Endothelial dysfunction in the pathogenesis of pre-eclampsia. , 2014, Frontiers in bioscience.

[253]  N. Shehata,et al.  The use of anti-fibrinolytic agents in patients with HHT: a retrospective survey , 2014, Annals of Hematology.

[254]  M. Humbert,et al.  Definition and classification of pulmonary hypertension. , 2013, Handbook of experimental pharmacology.

[255]  A. Pries,et al.  Regulation of endothelial connexin40 expression by shear stress. , 2012, American journal of physiology. Heart and circulatory physiology.

[256]  B. Seon,et al.  Endoglin-targeted cancer therapy. , 2011, Current drug delivery.

[257]  G. Borthwick,et al.  Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH , 2009, Laboratory Investigation.

[258]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[259]  J. Han,et al.  Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. , 2006, Microvascular research.

[260]  H. Arthur,et al.  Endoglin expression in early development is associated with vasculogenesis and angiogenesis , 2002, Mechanisms of Development.

[261]  N. Seidah,et al.  Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. , 2001, The American journal of pathology.

[262]  T. Rapoport,et al.  JCB Article , 2001 .

[263]  D. Marchuk,et al.  Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. , 2000, Developmental biology.

[264]  Y. Lui,et al.  Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. , 2000, Chest.

[265]  Lucia Ballerini,et al.  Modulation of Arterial Growth of the Rabbit Carotid Artery Associated with Experimental Elevation of Blood Flow , 1998 .

[266]  N. McKee,et al.  The distribution of centrosomes in endothelial cells of the rat aorta and inferior vena cava. , 1997, Artery.

[267]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.

[268]  Identification and functional analysis of endothelial tip cell–enriched genes , 2022 .